We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biomarkers Identify Sepsis-Induced Organ Failure

By HospiMedica staff writers
Posted on 13 Dec 2006
A set of gene expression biomarkers have been identified that closely correlate with the cause of multiorgan failure in sepsis.

In a pilot study comprising 650 patients on a daily basis, the classifiers derived from more than 2,000 microarray analyses allowed the reliable differentiation between infectious and non-infectious causes of multiorgan failure.

The new classifiers will be incorporated into CE-approved biochip/quantitative polymerase chain reaction (qPCR) assays and validated against thousands of clinical blood samples. More...
In the area of intensive-care medicine worldwide, there is a high medical demand for reliable, quick, and easy-to-use test systems. When identified early and reliably, sepsis could be successfully treated using patient-tailored therapies, thus improving considerably a patient's chances of survival.

The robust gene expression signature for sepsis was discovered by SIRS-Lab GmbH (Jena, Germany), a molecular diagnostics company developing tests for life-threatening infections. The results emerged from collaboration between SIRS-Lab, the University Clinics Jena, and Analytik Jena AG, supported by the German Federal Ministry for Education and Research. The cooperation with the University Clinics Jena granted SIRS-Lab access to a worldwide bio-bank with clinical samples from hundreds of sepsis patients, which were essential for testing new biomarker candidates.

SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening sepsis, one of the major causes of death in hospitals across the world.



Related Links:
SIRS-Lab

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.